Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSWI + PCA versus PCEA for postoperative pain after HPB laparotomy
NL-OMON42243Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine, morphine and sufentanil in postoperative pain (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Overall Benefit of Analgesic Score. Started Jan 2015; status: active, not recruiting.
02
Drugs
bupivacainemorphinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NL-OMON42243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42243.